Australian cash underneath a piggy bank. (Source: file)
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Intelligent Monitoring Group (IMB) raises $3.4 million from the retail component of its entitlement offer to fund acquisitions and working capital
  • The company received applications for more than 1.5 million shares for about $229,000
  • The shortfall will be taken up by sub-underwriters, including existing shareholder Black Crane Asia Pacific Opportunities
  • The funds will be directed towards the company’s acquisition of Australian Inland Security and Mammoth
  • Shares are trading 16.5 per cent lower at 9.6 cents each at market close

Intelligent Monitoring Group (IMB) has raised $3.4 million from the retail component of its entitlement offer to fund acquisitions and working capital.

The company received applications for more than 1.5 million shares for about $229,000.

The shortfall will be taken up by sub-underwriters, including existing shareholder Black Crane Asia Pacific Opportunities.

Black Crane is controlled by IMB’s Chairman, Peter Keenan, and it subscribed for about $2.3 million in new shares under the retail component.

A total of 22.7 million new shares will be issued at a price of 15 cents each on Wednesday, June 22.

Combined with the institutional component, a total of $8.4 million was raised.

The funds will be directed towards the company’s acquisition of Australian Inland Security and Mammoth.

Shares have fallen 16.5 per cent today to close at 9.6 cents each.

IMB by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next